In fully grown skin rafts, overnight supplementation with Tretinoin induced RDH10 expression in human epidermis compared with vehicle supplied in culture medium. In J1 mouse ESCs, Tretinoin treatment significantly downregulated 1132 genes and significantly upregulated 1093 genes, as assessed by microarray analysis. sRNA sequencing in Tretinoin-treated J1 mouse ESCs identified 31 miRNAs significantly upregulated and 175 miRNAs significantly downregulated. [1,2]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
RDH10 transcript induction in human epidermal skin rafts
Cell-based study · fully grown skin rafts; four rafts [1]
Fully grown skin rafts received Tretinoin at 0.1 μM in culture medium overnight. Compared with vehicle supplied in culture medium, treatment induced RDH10 expression in human epidermis, assessed by qPCR.
Literature-Reported Treatment Conditions
- Treatment concentration
- 0.1 μM
- Exposure duration
- overnight
- Method
- supplemented skin raft culture medium
- Co-treatment
- Other interventions in this design: cholera toxin; insulin; apo-transferrin; hydrocortisone-21; human epidermal growth factor. Compound effect isolated by the comparison: vehicle supplied in culture medium.
- Reported limits
- Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: Tretinoin; Compound label in the paper: ATRA
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and Methods > 1. Preparation of organotypic skin rafts and treatment with UAB30 or bexarotene (S6, S9, S10); Materials and Methods > 4. QPCR analysis (S48); Results (S114, S115)
levels of RDH10 transcripts by qPCR: levels of RDH10 transcripts by qPCR; comparator: vehicle supplied in culture medium — Results (S114, S115)
Gene expression changes in mouse embryonic stem cells
Cell-based study · J1 mouse ESCs [2]
J1 mouse ESCs received Tretinoin at 1 μM for 24 h, with an equal volume of DMSO as control. Gene expression microarray analysis identified 1132 significantly downregulated genes and 1093 significantly upregulated genes.
Literature-Reported Treatment Conditions
- Treatment concentration
- 1 μM
- Exposure duration
- 24 h
- Method
- added to mESCs
- Vehicle
- dimethyl sulfoxide (DMSO)
Methods and source locations
Compound reported in the paper: Tretinoin; Compound label in the paper: Retinoic Acid
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > Microarray profiling demonstrates that RA induces ectodermal marker expression in ES cells (S5, S6); Materials and Methods > Cell culture and treatment (S65, S66); Materials and Methods > RNA isolation, microarrays and sRNA high-throughput sequencing (S77, S78)
gene expression microarray analysis: gene expression microarray analysis; comparator: an equal volume of DMSO — Results > Microarray profiling demonstrates that RA induces ectodermal marker expression in ES cells (S5, S6)
MicroRNA expression changes in mouse embryonic stem cells
Cell-based study · J1 mouse ESCs [2]
J1 mouse ESCs received Tretinoin at 1 μM for 24 h, with an equal volume of DMSO as control. sRNA sequencing identified 31 significantly upregulated miRNAs and 175 significantly downregulated miRNAs.
Literature-Reported Treatment Conditions
- Treatment concentration
- 1 μM
- Exposure duration
- 24 h
- Method
- added to mESCs
- Vehicle
- dimethyl sulfoxide (DMSO)
Methods and source locations
Compound reported in the paper: Tretinoin; Compound label in the paper: Retinoic Acid
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > Multiple microRNA are suppressed in mESCs by RA treatment (S40, S41); Materials and Methods > Cell culture and treatment (S65, S66); Materials and Methods > RNA isolation, microarrays and sRNA high-throughput sequencing (S77, S78)
sRNA sequencing: sRNA sequencing; comparator: an equal volume of DMSO — Results > Multiple microRNA are suppressed in mESCs by RA treatment (S40, S41)